These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 30856108

  • 1. Impact of extractable nuclear antigen, anti-double stranded DNA, antiphospholipid antibody, and anticardiolipin antibody positivity on obstetrical complications and pregnancy outcomes.
    Tanacan A, Beksac MS, Orgul G, Duru S, Sener B, Karaagaoglu E.
    Hum Antibodies; 2019; 27(2):135-141. PubMed ID: 30856108
    [Abstract] [Full Text] [Related]

  • 2. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies.
    Chauleur C, Galanaud JP, Alonso S, Cochery-Nouvellon E, Balducchi JP, Marès P, Fabbro-Peray P, Gris JC.
    J Thromb Haemost; 2010 Apr; 8(4):699-706. PubMed ID: 20088936
    [Abstract] [Full Text] [Related]

  • 3. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G, Rizzo N, Facchinetti F, Dall'Asta A, Visentin S, Sarno L, Xodo S, Bernabini D, Monari F, Roman A, Eke AC, Hoxha A, Ruffatti A, Schuit E, Martinelli P, PREGNANTS (PREGNancy in women with ANTiphospholipid Syndrome) working group.
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [Abstract] [Full Text] [Related]

  • 4. Antiphospholipid syndrome characteristics and adverse pregnancy outcomes after 20 weeks of pregnancy.
    Gabbay-Benziv R, Zafrir-Danieli H, Blickstein D, Shmueli A, Salman L, Hadar E.
    Int J Gynaecol Obstet; 2018 Aug; 142(2):214-220. PubMed ID: 29676461
    [Abstract] [Full Text] [Related]

  • 5. Antiphospholipid antibodies and the risk of adverse pregnancy outcomes in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Huang J, Zhu Q, Wang B, Wang H, Xie Z, Zhu X, Zhao T, Yang Z.
    Expert Rev Clin Immunol; 2024 Jul; 20(7):793-801. PubMed ID: 38445835
    [Abstract] [Full Text] [Related]

  • 6. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.
    Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, Petri M, Porter TF, Sammaritano L, Stephenson MD, Buyon J, Salmon JE.
    Arthritis Rheum; 2012 Jul; 64(7):2311-8. PubMed ID: 22275304
    [Abstract] [Full Text] [Related]

  • 7. [Humoral Immunity Abnormalities in Advanced Maternal-Age Women With Recurrent Spontaneous Abortion: A Single Center Study].
    Li G, Deng X, Bao S.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 May 20; 55(3):605-611. PubMed ID: 38948271
    [Abstract] [Full Text] [Related]

  • 8. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies.
    Ogishima D, Matsumoto T, Nakamura Y, Yoshida K, Kuwabara Y.
    Pathol Int; 2000 Mar 20; 50(3):224-9. PubMed ID: 10792786
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T, Kaczor MP, Celińska-Löwenhoff M, Polański S, Musiał J.
    Thromb Res; 2017 May 20; 153():90-94. PubMed ID: 28363116
    [Abstract] [Full Text] [Related]

  • 10. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M, Jara LJ, Ramos A, Barile L, Machado G, García-De La Torre I.
    Rheumatol Int; 2002 Aug 20; 22(4):142-7. PubMed ID: 12172952
    [Abstract] [Full Text] [Related]

  • 11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec 20; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 12. Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies.
    Lazzaroni MG, Fredi M, Andreoli L, Chighizola CB, Del Ross T, Gerosa M, Kuzenko A, Raimondo MG, Lojacono A, Ramazzotto F, Zatti S, Trespidi L, Meroni PL, Pengo V, Ruffatti A, Tincani A.
    Front Immunol; 2019 Dec 20; 10():1948. PubMed ID: 31475009
    [Abstract] [Full Text] [Related]

  • 13. [Frequency of antiphospholipid syndrome in women with pregnancy loss in multicenter study in Poland].
    Skrzypczak J, Rajewski M, Wirstlein P, Goździewicz T, Zimmer M, Wołczyński S, Leszczyńska-Gorzelak B, Breborowicz G, Ludwikowski G.
    Ginekol Pol; 2011 Oct 20; 82(10):749-54. PubMed ID: 22379938
    [Abstract] [Full Text] [Related]

  • 14. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P, Lehtonen KV, Javela K, Puurunen M.
    Lupus; 2014 Dec 20; 23(14):1468-76. PubMed ID: 25164304
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pregnancy failure in patients with obstetric antiphospholipid syndrome with conventional treatment: the influence of a triple positive antibody profile.
    Latino JO, Udry S, Aranda FM, Perés Wingeyer SDA, Fernández Romero DS, de Larrañaga GF.
    Lupus; 2017 Aug 20; 26(9):983-988. PubMed ID: 28173738
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiphospholipid antibody profile: implications for the evaluation and management of patients.
    Tincani A, Andreoli L, Casu C, Cattaneo R, Meroni P.
    Lupus; 2010 Apr 20; 19(4):432-5. PubMed ID: 20353983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.